Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis

Angiopoietin-2 (Ang-2) plays a pivotal role in pathological vascular remodeling and angiogenesis. Both vascular mechanisms are active in patients with end-stage renal disease (ESRD) and may contribute to the high mortality in these patients. The aim of this multicenter prospective cohort study was t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chu, Chang (VerfasserIn) , Chen, Xin (VerfasserIn) , Hasan, Ahmed A (VerfasserIn) , Szakallova, Angelika (VerfasserIn) , Krämer, Bernhard (VerfasserIn) , Tepel, Martin (VerfasserIn) , Hocher, Berthold (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2022
In: Nephrology, dialysis, transplantation
Year: 2022, Jahrgang: 37, Heft: 7, Pages: 1348-1356
ISSN:1460-2385
DOI:10.1093/ndt/gfab332
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/ndt/gfab332
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/ndt/article/37/7/1348/6430873?login=true
Volltext
Verfasserangaben:Chang Chu, Xin Chen, Ahmed A Hasan, Angelika Szakallova, Bernhard K Krämer, Martin Tepel and Berthold Hocher

MARC

LEADER 00000caa a2200000 c 4500
001 1877492884
003 DE-627
005 20240624092751.0
007 cr uuu---uuuuu
008 240109s2022 xx |||||o 00| ||eng c
024 7 |a 10.1093/ndt/gfab332  |2 doi 
035 |a (DE-627)1877492884 
035 |a (DE-599)KXP1877492884 
035 |a (OCoLC)1425215759 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Chu, Chang  |d 1992-  |e VerfasserIn  |0 (DE-588)119616228X  |0 (DE-627)1678018716  |4 aut 
245 1 0 |a Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis  |c Chang Chu, Xin Chen, Ahmed A Hasan, Angelika Szakallova, Bernhard K Krämer, Martin Tepel and Berthold Hocher 
246 3 3 |a Angiopoietin-two predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis 
264 1 |c 2022 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.01.2024 
520 |a Angiopoietin-2 (Ang-2) plays a pivotal role in pathological vascular remodeling and angiogenesis. Both vascular mechanisms are active in patients with end-stage renal disease (ESRD) and may contribute to the high mortality in these patients. The aim of this multicenter prospective cohort study was to investigate baseline serum Ang-2 concentrations in ESRD patients on hemodialysis (HD) for their ability to predict all-cause mortality.We conducted a prospective cohort study in 340 stable HD patients from different chronic dialysis centers in Berlin, Germany. The primary endpoint was all-cause mortality during a 5-year follow-up period. Blood samples and clinical data were collected at baseline. Serum Ang-2 was measured with a validated enzyme-linked immunosorbent assay (Biomedica, Vienna, Austria).A total of 313 HD patients (206 men and 107 women) were finally included in the study. Receiver operating characteristic (ROC) analysis of Ang-2 concentrations yielded an area under the curve (AUC) of 0.65 (P < 0.0001) for predicting all-cause mortality in the entire study population and was used to determine the optimal cut-off (111.0 pmol/L) for all-cause mortality. Kaplan-Meier survival analysis indicated that male but not female end-stage kidney disease patients on HD with higher Ang-2 concentrations had a significantly lower survival (log-rank test, P < 0.0001 and P = 0.380 for male and female patients, respectively). Multivariable Cox regression analyses adjusted for age, comorbidity, smoking, dialysis vintage, serum creatinine, hemoglobin, C-reactive protein, serum albumin, intact parathyroid hormone (iPTH), low-density lipoprotein (LDL) and Kt/V likewise indicated that elevated Ang-2 concentrations are associated with all-cause mortality in male {hazard ratio [HR] 3.294 [95% confidence interval (CI) 1.768-6.138]; P = 0.0002} but not in female end-stage kidney disease patients on HD [HR 1.084 (95% CI 0.476-2.467); P = 0.847].Ang-2 at baseline is independently associated with all-cause mortality in male ESRD patients on HD. 
700 1 |a Chen, Xin  |d 1991-  |e VerfasserIn  |0 (DE-588)1162096292  |0 (DE-627)1025535030  |0 (DE-576)507146719  |4 aut 
700 1 |a Hasan, Ahmed A  |e VerfasserIn  |4 aut 
700 1 |a Szakallova, Angelika  |e VerfasserIn  |4 aut 
700 1 |a Krämer, Bernhard  |d 1957-  |e VerfasserIn  |0 (DE-588)14017589X  |0 (DE-627)70358927X  |0 (DE-576)314926852  |4 aut 
700 1 |a Tepel, Martin  |e VerfasserIn  |4 aut 
700 1 |a Hocher, Berthold  |d 1962-  |e VerfasserIn  |0 (DE-588)12000397X  |0 (DE-627)696292173  |0 (DE-576)291991033  |4 aut 
773 0 8 |i Enthalten in  |t Nephrology, dialysis, transplantation  |d Oxford : Oxford Univ. Press, 1986  |g 37(2022), 7 vom: Juli, Seite 1348-1356  |h Online-Ressource  |w (DE-627)265778395  |w (DE-600)1465709-0  |w (DE-576)079420079  |x 1460-2385  |7 nnas  |a Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis 
773 1 8 |g volume:37  |g year:2022  |g number:7  |g month:07  |g pages:1348-1356  |g extent:9  |a Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis 
856 4 0 |u https://doi.org/10.1093/ndt/gfab332  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://academic.oup.com/ndt/article/37/7/1348/6430873?login=true  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240109 
993 |a Article 
994 |a 2022 
998 |g 12000397X  |a Hocher, Berthold  |m 12000397X:Hocher, Berthold  |d 60000  |d 61400  |e 60000PH12000397X  |e 61400PH12000397X  |k 0/60000/  |k 1/60000/61400/  |p 7  |y j 
998 |g 14017589X  |a Krämer, Bernhard  |m 14017589X:Krämer, Bernhard  |d 60000  |d 61400  |e 60000PK14017589X  |e 61400PK14017589X  |k 0/60000/  |k 1/60000/61400/  |p 5 
998 |g 1162096292  |a Chen, Xin  |m 1162096292:Chen, Xin  |p 2 
998 |g 119616228X  |a Chu, Chang  |m 119616228X:Chu, Chang  |p 1  |x j 
999 |a KXP-PPN1877492884  |e 4451564026 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Chu, Chang","family":"Chu","role":"aut","given":"Chang"},{"given":"Xin","role":"aut","family":"Chen","display":"Chen, Xin"},{"role":"aut","given":"Ahmed A","family":"Hasan","display":"Hasan, Ahmed A"},{"family":"Szakallova","display":"Szakallova, Angelika","given":"Angelika","role":"aut"},{"family":"Krämer","display":"Krämer, Bernhard","role":"aut","given":"Bernhard"},{"given":"Martin","role":"aut","family":"Tepel","display":"Tepel, Martin"},{"display":"Hocher, Berthold","family":"Hocher","given":"Berthold","role":"aut"}],"language":["eng"],"note":["Gesehen am 09.01.2024"],"titleAlt":[{"title":"Angiopoietin-two predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis"}],"origin":[{"dateIssuedDisp":"2022","dateIssuedKey":"2022"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis","title":"Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis"}],"recId":"1877492884","name":{"displayForm":["Chang Chu, Xin Chen, Ahmed A Hasan, Angelika Szakallova, Bernhard K Krämer, Martin Tepel and Berthold Hocher"]},"physDesc":[{"extent":"9 S."}],"relHost":[{"id":{"issn":["1460-2385"],"eki":["265778395"],"zdb":["1465709-0"]},"recId":"265778395","pubHistory":["1.1986 -"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"part":{"text":"37(2022), 7 vom: Juli, Seite 1348-1356","pages":"1348-1356","year":"2022","volume":"37","extent":"9","issue":"7"},"origin":[{"publisher":"Oxford Univ. Press","dateIssuedKey":"1986","dateIssuedDisp":"1986-","publisherPlace":"Oxford"}],"note":["Gesehen am 01-04-14"],"title":[{"title_sort":"Nephrology, dialysis, transplantation","title":"Nephrology, dialysis, transplantation"}],"titleAlt":[{"title":"Nephrology, dialysis, transplantation online"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysisNephrology, dialysis, transplantation"}],"id":{"doi":["10.1093/ndt/gfab332"],"eki":["1877492884"]}} 
SRT |a CHUCHANGCHANGIOPOIET2022